Amyloidosis: Recognition, Confirmation, Prognosis, and Therapy
- 1 May 1999
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 74 (5) , 490-494
- https://doi.org/10.1016/s0025-6196(11)65130-6
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Dose-Intensive Melphalan With Blood Stem-Cell Support for the Treatment of AL (Amyloid Light-Chain) Amyloidosis: Survival and Responses in 25 PatientsBlood, 1998
- Diagnosis and treatment of amyloidosisAnnals of the Rheumatic Diseases, 1997
- The Systemic AmyloidosesNew England Journal of Medicine, 1997
- A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and ColchicineNew England Journal of Medicine, 1997
- Hepatic Amyloidosis: Clinical Appraisal in 77 PatientsHepatology, 1997
- Amyloidosis: Prognosis and treatmentSeminars in Arthritis and Rheumatism, 1994
- Dialysis Support of Patients With Primary Systemic AmyloidosisArchives of internal medicine (1960), 1992
- Response rates and survival in primary systemic amyloidosisBlood, 1991